NeuroPrime vs Genius Song: Comparing Two Leading Memory Supplements

Thirty-one columns. That's what my brain-health tracking spreadsheet had grown to by the time I sat down to compare NeuroPrime against The Genius Song, and only one of those columns changed color the week that mattered. I'd built the thing expecting a wash between the two — a capsule versus an audio track, two very different memory supplements pulling at the same problem — and instead got a number I checked twice before I trusted it enough to write down. This is the full audit: what a cognitive tracking spreadsheet looks like when you run two products through it back to back, and which one actually earned its spot in my morning routine.

Quick disclosure before we get into the ledger: I use affiliate links here, and if you buy something through one of them I earn a commission — no extra cost to you, but worth saying plainly. I'm not a doctor and I've never worn a lab coat; I'm a retired accountant who got tired of forgetting names and started keeping score instead. Everything below comes from what I actually tracked, not from a bottle's marketing copy. Talk to your own doctor before starting anything new, especially if your memory feels like it's already overdrawn.

Setting Up a Cognitive Tracking Spreadsheet for Two Memory Supplements

Three decades of auditing Fortune 500 books taught me one thing above all: you don't trust a number you can't re-derive. So when I decided to test NeuroPrime against The Genius Song, I didn't just take capsules and hum along and see what happened — I built a sheet. Subjective clarity got its own column, scored one to ten. So did recall, tracked against how many names I could pull up without hesitating. Cost basis got a column too, though I'll admit it stayed more qualitative than I'd like — a retired accountant with a spreadsheet column he refuses to fill in with real numbers is its own kind of joke, and my wife has made it more than once.

Why Compare a Capsule to a Soundtrack?

Before either of these products, I'd already tried fixing the problem sideways. Melatonin, specifically — on the theory that bad sleep was quietly wrecking my recall, and that if I fixed sleep the fog would lift on its own. It didn't. The recall column sat flat for weeks, and eventually I dropped it and started looking at direct inputs instead of hoping sleep was the whole story. That's the mindset I carried into this comparison: stop guessing at the mechanism, just track the output.

NeuroPrime is the traditional route — capsules, a fixed dose, something you swallow with coffee. The Genius Song works differently: audio layers within the normal range of human hearing, meant to be played rather than swallowed. Comparing the two felt like comparing a short-term bond to a long-term index fund in my old portfolio reviews — different mechanisms, different time horizons, and no honest way to know which one fit better without running both through the same test.

The Capsule Phase: Testing NeuroPrime

I started with NeuroPrime through the winter months, two capsules with my morning coffee, sixty count per bottle. The routine itself felt familiar fast — a fixed asset in the morning, same as decades of coffee-and-inbox had been. Early on, the acute alertness column moved the most: on days with a full calendar, the sharpness showed up almost immediately, useful the way a strong cup of coffee is useful before a hard meeting.

What didn't move as much was the long-term column. In my notes on the premium margin, the acute-focus score stayed high while the sustained-calm score barely budged week over week. It reads less like a foundation and more like a tool for the days I needed to perform, closer to a deadline stimulant than a rebuild. I also weighed Neuro-Thrive as a cheaper fallback during this stretch. It's a reasonable product, but it didn't carry the same weight on high-stakes days that NeuroPrime did, so for the sake of the audit I kept NeuroPrime as the capsule benchmark.

Switching to The Genius Song

One evening after a rough stretch at bridge — I'd lost track of the bidding twice in one hand, which never used to happen — I put the capsules on the shelf and switched to The Genius Song. Nothing to swallow. You put on headphones and let the layered audio run, and I was skeptical going in — thirty years of hard numbers doesn't exactly prepare a person to trust a soundtrack for memory support. What did register with me was the Gravity score sitting at 136 on ClickBank, which in plain terms means a lot of buyers keep the product instead of refunding it. That's the kind of retention number that gets an accountant's attention faster than any testimonial.

The felt experience was different from the capsules almost immediately — less a jolt, more a slow drop in background noise. Around week six of the audio phase, my wife mentioned a neighbor's name at the table, and it came back to me whole, no stall, no reaching. I didn't make much of it until I checked that week's row and saw the recall column had already ticked up before I'd consciously noticed anything changing. If you want the deeper frequency breakdown, I laid it out separately in my notes comparing The Genius Song and The Brain Song.

I mentioned the whole experiment to Clifford Achebe, a friend from my old client list who now runs a medical supply company and doesn't get excited about health products without paperwork behind them. He asked if the audio worked better than his golf swing, which, knowing Clifford's golf swing, was not a high bar to clear. Grounded as he is, even he admitted the sustained-column data was hard to argue with once I showed him the sheet.

What Did the Numbers Actually Show?

By midsummer the contrast in the spreadsheet was hard to miss. NeuroPrime is the acute specialist — good for the day you're defending a position and need sharpness on demand. The Genius Song, and its sibling product The Brain Song, are built for the baseline instead: the number that doesn't crash by mid-afternoon. Reading through my morning emails with the audio running gave me a floor of clarity I never got from the capsules, no matter how high the acute score spiked.

There's also the plain math of upkeep. No bottles to reorder, no pills to remember, and once you own the tracks the recurring cost drops to zero — the kind of one-time-investment-for-ongoing-utility structure a former auditor finds hard to walk past. My wife still gives me a look when the headphones come out at the kitchen table, but she hasn't had to remind me of anyone's name in a long while.

If there's one line worth underlining in the whole spreadsheet, it's this: the product that wins the audit isn't the one with the tallest single spike, it's the one whose column keeps climbing after you've stopped watching it closely. That's the test I'd apply to anything you're considering, not just these two.

For anyone starting their own version of this audit, The Genius Song is where I'd point you first — easier on the stomach, easier on the recurring budget, and the data in my own sheet backs it consistently. If the fog is the thing bothering you before you even pick a product, it's worth identifying what's actually behind it so you're not guessing at inputs.

If you're ready to run your own trial, start with the audio approach — it's the lower-friction way to see whether this kind of support does anything for you. You can check out The Genius Song here and see how it lines up against your own numbers.